Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAM17 | P78536 | 4/20 | 0.74 |
| ▸ | MMP2 | P08253 | 13/20 | 0.37 |
| ▸ | MMP3 | P08254 | 12/20 | 0.37 |
| ▸ | MMP7 | P09237 | 11/20 | 0.37 |
| ▸ | MMP1 | P03956 | 11/20 | 0.37 |
| ▸ | MMP8 | P22894 | 2/20 | 0.37 |
| ▸ | MMP9 | P14780 | 2/20 | 0.37 |
| ▸ | MMP12 | P39900 | 1/20 | 0.37 |
| ▸ | MMP13 | P45452 | 1/20 | 0.37 |
| ▸ | MMP14 | P50281 | 1/20 | 0.37 |
| ▸ | FCER2 | P06734 | 4/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7104655 | 0.97 | ADAM17 (0.75) | ADAM17MMP2MMP3MMP7MMP1 | |
| SCHEMBL7104724 | 0.94 | ADAM17 (0.78) | ADAM17MMP2MMP3MMP7MMP1 | |
| SCHEMBL7104784 | 0.92 | ADAM17 (0.63) | ADAM17MMP2MMP3MMP7MMP1 | |
| SCHEMBL7103548 | 0.90 | ADAM17 (0.64) | ADAM17MMP2MMP3MMP7MMP1 | |
| SCHEMBL7103638 | 0.90 | ADAM17 (0.74) | ADAM17MMP2MMP3MMP7MMP1 | |
| SCHEMBL7100103 | 0.88 | ADAM17 (0.71) | ADAM17MMP2MMP3MMP7MMP1 | |
| SCHEMBL7100583 | 0.87 | ADAM17 (0.60) | ADAM17MMP2MMP3MMP7MMP1 | |
| SCHEMBL7100347 | 0.86 | ADAM17 (0.66) | ADAM17MMP2MMP3MMP7MMP1 | |
| SCHEMBL13274076 | 0.85 | ADAM17 (1.00) | ADAM17MMP2MMP3MMP7MMP1 | |
| SCHEMBL4481744 | 0.85 | ADAM17 (1.00) | ADAM17MMP2MMP3MMP7MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1133471-B1 | HYDRAZINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2003-09-17 | — | — | EP | claimed |
| US-6265446-B1 | ANTIINFLAMMATORY AGENTS; AUTOIMMUNE DISEASES | HOFFMANN-LA ROCHE INC.. | 2001-07-24 | — | — | US | claimed |
| EP-1133471-B1 | HYDRAZINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2003-09-17 | — | — | EP | disclosed |
| EP-1133471-A1 | HYDRAZINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2001-09-19 | — | — | EP | disclosed |
| US-6265446-B1 | ANTIINFLAMMATORY AGENTS; AUTOIMMUNE DISEASES | HOFFMANN-LA ROCHE INC.. | 2001-07-24 | — | — | US | disclosed |
| WO-2000032570-A1 | HYDRAZINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2000-06-08 | — | — | WO | disclosed |